A World Health Organization (WHO) panel of International experts recommends the use of Merck & Co.'s COVID-19 antiviral

COVID-19 pandemic

A World Health Organization (WHO) panel of International experts recommends the use of Merck & Co.'s COVID-19 antiviral pill Molnupiravir for high-risk patients.

Changes

A World Health Organization (WHO) panel of International experts recommends the use of Merck & Co's COVID-19 antiviral pill Molnupiravir for high-risk patients
2022-03-03 11:06:13 (First version)

A World Health Organization (WHO) panel of International experts recommends the use of Merck & Co.'s COVID-19 antiviral pill Molnupiravir for high-risk patients.
(Current version)

Offstream
news

2022-03-2

COVID-19 pandemic

A World Health Organization (WHO) panel of International experts recommends the use of Merck & Co.'s COVID-19 antiviral pill Molnupiravir for high-risk patients.

Changes

Related